Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term imidafenacin study in overactive bladder
jRCT2080220423Phase 3
- Sponsor
- Kyorin Pharmaceutical
- Start
- Aug 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of imidafenacin in overactive bladder (OAB), sponsored by Kyorin Pharmaceutical.
02
Drugs
imidafenacin
03
Conditions
overactive bladder (OAB)
Beyond the preview
Go deeper on jRCT2080220423.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080220423.